Doxycycline Monohydrate
NDC Package 0591-0410-01
Package Information
Doxycycline Monohydrate is a medication used to treat a wide variety of bacterial infections, including those that cause acne. Marketed by Actavis Pharma, Inc., this product is identified by NDC 0591-0410 and is authorized under FDA application NDA050641.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0591 - Actavis Pharma, Inc.
- 0591-0410 - Doxycycline Monohydrate
- 0591-0410-01 - 100 CAPSULE in 1 BOTTLE
- 0591-0410 - Doxycycline Monohydrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0591-0410-01 identifies a specific commercial package of 100 capsule in 1 bottle of Doxycycline Monohydrate, labeled by Actavis Pharma, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Actavis Pharma, Inc. on February 07, 2005. The current certification is valid through January 31, 2020.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Actavis Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00591041001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.